COMPANY

Hexamer Therapeutics

Keywords: oncology infectious disease vaccine infectious diseases cancer

Location: Pullman, WA · source · Sep 15, 2026

Profile checked Oct 10, 2026

Funding and NIH signals

SEC Form D raise Raised $500K (Form D filed Sep 15, 2026). SEC Form D 0001797915-26-000002 (Sep 15, 2026)
Evidence (1 event)
- Sep 15, 2026 · SEC Form D 0001797915-26-000002
  Name of Issuer: Hexamer Therapeutics, Inc; CIK: 1797915; Address: Pullman, WA; Submission type: D; Filing date: 2026-09-15; Industry Group: Biotechnology; Date of First Sale: 2026-07-07; Types of Securities Offered: Equity, Option/warrant; Business combination transaction: false; Total Offering Amount: 2500000; Total Amount Sold: 500000; Federal exemptions: 06b

Job counts as of Oct 18, 2026. All funding and NIH signals